243 related articles for article (PubMed ID: 25051917)
1. Correlations of IFN-γ genetic polymorphisms with susceptibility to breast cancer: a meta-analysis.
Li CJ; Dai Y; Fu YJ; Tian JM; Li JL; Lu HJ; Duan F; Li QW
Tumour Biol; 2014 Jul; 35(7):6867-77. PubMed ID: 25051917
[TBL] [Abstract][Full Text] [Related]
2. Genetic polymorphisms in VDR, ESR1 and ESR2 genes may contribute to susceptibility to Parkinson's disease: a meta-analysis.
Gao Z; Fu HJ; Xue JJ; Wu ZX; Zhao LB
Mol Biol Rep; 2014 Jul; 41(7):4463-74. PubMed ID: 24595449
[TBL] [Abstract][Full Text] [Related]
3. Relationships between TCF7L2 genetic polymorphisms and polycystic ovary syndrome risk: a meta-analysis.
Shen WJ; Li TR; Hu YJ; Liu HB; Song M
Metab Syndr Relat Disord; 2014 May; 12(4):210-9. PubMed ID: 24611738
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor-beta1 polymorphisms and breast cancer risk: a meta-analysis based on 27 case-control studies.
Qi X; Zhang F; Yang X; Fan L; Zhang Y; Chen L; Zhou Y; Chen X; Zhong L; Jiang J
Breast Cancer Res Treat; 2010 Jul; 122(1):273-9. PubMed ID: 20309626
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-18 genetic polymorphisms contribute differentially to the susceptibility to Crohn's disease.
Gao SJ; Zhang L; Lu W; Wang L; Chen L; Zhu Z; Zhu HH
World J Gastroenterol; 2015 Jul; 21(28):8711-22. PubMed ID: 26229413
[TBL] [Abstract][Full Text] [Related]
6. Three novel functional polymorphisms in the promoter of FGFR2 gene and breast cancer risk: a HuGE review and meta-analysis.
Zhou L; Yao F; Luan H; Wang Y; Dong X; Zhou W; Wang Q
Breast Cancer Res Treat; 2012 Dec; 136(3):885-97. PubMed ID: 23124475
[TBL] [Abstract][Full Text] [Related]
7. Correlations of SELE and SELP genetic polymorphisms with myocardial infarction risk: a meta-analysis and meta-regression.
Zhao YJ; Yang X; Ren L; Cai AS; Zhang YF
Mol Biol Rep; 2014 Jul; 41(7):4521-32. PubMed ID: 24639176
[TBL] [Abstract][Full Text] [Related]
8. Relationships of LDLR genetic polymorphisms with cerebral infarction: a meta-analysis.
Yan HC; Wang W; Dou CW; Tian FM; Qi ST
Mol Biol Rep; 2014 Jul; 41(7):4425-34. PubMed ID: 24595448
[TBL] [Abstract][Full Text] [Related]
9. Association between five polymorphisms in vascular endothelial growth factor gene and urinary bladder cancer risk: A systematic review and meta-analysis involving 6671 subjects.
Song Y; Yang Y; Liu L; Liu X
Gene; 2019 May; 698():186-197. PubMed ID: 30849545
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphisms in the IL-18 gene and ulcerative colitis risk: a meta-analysis.
Wang Y; Tong J; Chang B; Wang BF; Zhang D; Wang BY
DNA Cell Biol; 2014 Jul; 33(7):438-47. PubMed ID: 24621393
[TBL] [Abstract][Full Text] [Related]
11. XPD Asp312Asn and Lys751Gln polymorphisms and breast cancer susceptibility: a meta-analysis.
Yan Y; Liang H; Light M; Li T; Deng Y; Li M; Li S; Qin X
Tumour Biol; 2014 Mar; 35(3):1907-15. PubMed ID: 24101192
[TBL] [Abstract][Full Text] [Related]
12. A trial sequential meta-analysis of IFN-γ +874 A>T (rs2430561) gene polymorphism and extrapulmonary tuberculosis risk.
Mandal RK; Wahid M; Jawed A; Dar SA; Panda AK; Akhter N; Lohani M; Mishra BN; Khan S; Areeshi MY; Haque S
Microb Pathog; 2019 May; 130():1-9. PubMed ID: 30825502
[TBL] [Abstract][Full Text] [Related]
13. Correlations of MTHFR 677C>T polymorphism with cardiovascular disease in patients with end-stage renal disease: a meta-analysis.
Gao XH; Zhang GY; Wang Y; Zhang HY
PLoS One; 2014; 9(7):e102323. PubMed ID: 25050994
[TBL] [Abstract][Full Text] [Related]
14. Functional polymorphisms of the MAO gene with Parkinson disease susceptibility: a meta-analysis.
Sun YX; Wang XH; Xu AH; Zhao JH
J Neurol Sci; 2014 Oct; 345(1-2):97-105. PubMed ID: 25066260
[TBL] [Abstract][Full Text] [Related]
15. Association between ERα gene Pvu II polymorphism and breast cancer susceptibility: A meta-analysis.
Zhang ZL; Zhang CZ; Li Y; Zhao ZH; Yang SE
Medicine (Baltimore); 2018 Apr; 97(17):e0317. PubMed ID: 29702977
[TBL] [Abstract][Full Text] [Related]
16. Relationships between CYP1A1 genetic polymorphisms and bladder cancer risk: a meta-analysis.
Wang Y; Kong CZ; Zhang Z; Yang CM; Li J
DNA Cell Biol; 2014 Mar; 33(3):171-81. PubMed ID: 24552248
[TBL] [Abstract][Full Text] [Related]
17. Interferon gamma +874 T/A polymorphism increases the risk of cervical cancer: evidence from a meta-analysis.
Sun Y; Lu Y; Pen Q; Li T; Xie L; Deng Y; Qin A
Tumour Biol; 2015 Jun; 36(6):4555-64. PubMed ID: 25649976
[TBL] [Abstract][Full Text] [Related]
18. Association between 5p12 genomic markers and breast cancer susceptibility: evidence from 19 case-control studies.
Wang X; Zhang L; Chen Z; Ma Y; Zhao Y; Rewuti A; Zhang F; Fu D; Han Y
PLoS One; 2013; 8(9):e73611. PubMed ID: 24039999
[TBL] [Abstract][Full Text] [Related]
19. IFN-γ +874 T/A polymorphisms contributes to cervical cancer susceptibility: a meta-analysis.
Liu N; Song Y; Shi W
Int J Clin Exp Med; 2015; 8(3):4008-15. PubMed ID: 26064303
[TBL] [Abstract][Full Text] [Related]
20. Five common functional polymorphisms in microRNAs (rs2910164, rs2292832, rs11614913, rs3746444, rs895819) and the susceptibility to breast cancer: evidence from 8361 cancer cases and 8504 controls.
Dai ZJ; Shao YP; Wang XJ; Xu D; Kang HF; Ren HT; Min WL; Lin S; Wang M; Song ZJ
Curr Pharm Des; 2015; 21(11):1455-63. PubMed ID: 25483824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]